The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s

Social Psychiatry and Psychiatric Epidemiology

Volumn 46, Issue 2, 2011, Pages 137-142

  Donoghue, Kim ^a   Medley, Ian ^b   Brewin, John ^c   Glazebrook, Cristine ^a   Mason, Peter ^d   Cantwell, Roch ^e   Jones, Peter B ^f   Harrison, Glynn ^g   Doody, Gillian A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Mandala Centre   (United Kingdom)

^c NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^d St Catherine's Hospital   (United Kingdom)

^e SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Epidemiology; Psychosis; Substance misuse

Indexed keywords

ADDICTION; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANNABIS ADDICTION; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PSYCHOSIS; RESIDENTIAL CARE; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CATCHMENT AREA (HEALTH); COHORT STUDIES; COMORBIDITY; FEMALE; GREAT BRITAIN; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MARIJUANA ABUSE; MIDDLE AGED; PREJUDICE; PREVALENCE; PROGNOSIS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 79951812862     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-009-0175-5     Document Type: Article

References (38)

1. Cantor-Graae E, Nordstrom L, McNeil T (2001) Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 48:69-82 (Pubitemid 32241184)
2. Owen RR, Fischer EP, Booth BM, Cuffel BJ (1996) Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 47:853-858 (Pubitemid 26264738)
3. Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course or recent-onset schizophrenic disorder. Arch Gen Psychiatry 51:273-279 (Pubitemid 24127299)
4. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. JAMA 264:2511-2518
5. McCreadie RG (2002) Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry 181:321-325
6. Green B, Young R, Kavanagh D (2005) Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatry 187:306-313 (Pubitemid 41442380)
7. Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R (2007) Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 42:117-124 (Pubitemid 46647112)
8. Carrá G, Johnson S (2009) Variation in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK: a systematic review. Soc Psychiatry Psychiatr Epidemiol 44:429-447
9. Larsen TK, Melle I, Auestad B, Friis F, Haahr U, Johannessen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan TH (2006) Substance abuse in first-episode non-affective psychosis. Schizophr Res 88:55-62 (Pubitemid 44693253)
10. Moore TH, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319-328 (Pubitemid 47094993)
11. Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB (2007) Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 102:597-606 (Pubitemid 46398826)
12. Brewin J, Cantwell R, Dalkin T, Fox R, Medley I, Glazebrook C, Kwiecinski R, Harrison G (1997) Incidence of schizophrenia in Nottingham: a comparison of two cohorts, 1978-80 and 1992-94. Br J Psychiatry 171:140-144 (Pubitemid 27345146)
13. Fearon P, Kirkbride JB, Morgan C, Dazzan P, Morgan K, Lloyd T, Hutchinson G, Tarrant J, Fung WA, Holloway J, Mallett R, Harrison G, Leff J, Jones PB, Murray RM (2006) Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC ÆSOP study. Psychol Med 36:1541-1550
14. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A (1992) Schizophrenia: manifestations, incidence, and course in different cultures - a World Health Organisation ten-country study. Psychol Med Monogr Suppl 20:1-97
15. World Health Organisation (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. WHO, Geneva
16. Cooper JE, Goodhead D, Craig T, Harris M, Howat J, Korer J (1987) The incidence of schizophrenia in Nottingham. Br J Psychiatry 151:619-626 (Pubitemid 18025254)
17. World Health Organisation (1994) Schedules for the assessment in neuropsychiatry (SCAN) version 2.0. WHO, Geneva
18. Andreasen NC (1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39:784-788
19. Bernadt MW, Murray RM (1986) Psychiatric disorder, drinking and alcoholism: what are the links? Br J Psychiatry 148:393-400
20. Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, Lloyd T, Holloway J, Hutchinson G, Leff JP, Mallett RM, Harrison GL, Murray RM, Jones PB (2006) Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center ÆSOP study. Arch Gen Psychiatry 63:250-258 (Pubitemid 43345348)
21. SPSS for Windows (2005) Rel. 14.0.0 2005. SPSS Inc., Chicago
22. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Hillsdale, NJ, Erlbaum
23. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175-191
24. Koster A, Lajer M, Lindhardt A, Rosenbaum B (2001) Gender differences in first episode psychosis. Soc Psychiatry Psychiatr Epidemiol 43:940-946
25. Hambrecht M, Hafner H (1996) Substance abuse and the onset of schizophrenia. Biol Psychiatry 40:1155-1163 (Pubitemid 26400880)
26. Van Mastrigt S, Addington J, Addington D (2004) Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 39:69-72 (Pubitemid 39369110)
27. Rabinowitz J, Bromet E, Lavelle J, Carlson G, Kovasznay B, Schwartz J (1998) Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol Med 28:1411-1419 (Pubitemid 28521606)
28. Ramsay M, Partridge S (1999) Drug misuse declared in 1998: results from the British crime survey. Home Office Research Study 197. Home Office, London
29. Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD (2006) Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry 189:229-234 (Pubitemid 44343467)
30. Bartels SJ, Teague GB, Drake RE, Clark RE, Bush PW, Noordsy DL (1993) Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis 181:227-232 (Pubitemid 23233328)
31. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G (2002) Self reported cannabis use as a risk factor for schizophrenia in swedish conscripts of 1969: historical cohort study. BMJ 325:1199-1201 (Pubitemid 35398782)
32. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002) Cannabis use in adolescents and risk for adult psychosis: longitudinal prospective study. BMJ 325:1212-1213 (Pubitemid 35398785)
33. Fergusson DM, Horwood LJ, Swain-Campbell NR (2003) Cannabis dependence and psychotic symptoms in young people. Psychol Med 33:15-21 (Pubitemid 36113396)
34. Bone C, Waldron SJ (1998) New trends in illicit cannabis cultivation in the United Kingdom of Great Britain and Northern Ireland. Bull Narc 50:117-128 (Pubitemid 128453978)
35. Potter DJ, Clark P, Brown M (2005) Potency of R9-Thc and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci 53:90-94 (Pubitemid 351239216)
36. Hoare J, Flatley J (2008) Drug misuse declared: findings from the 2007/08 British crime survey. Home Office Statistical Bulletin, 13/08. Home Office, London
37. Martin G, Wilkinson A, Kapur B (1988) Validation of self-reported cannabis use by urine analysis. Addict Behav 13:147-150
38. Kedzior K, Badcock J, Martin-Ivorson M (2006) Validity and consistency of self-reports regarding substance use in general research volunteers, including regular cannabis users and schizophrenia patients. Subst Use Misuse 41:743-750